| 
Leptin | Resistin
| TNF | Adiponectin | Others
| References
Obesity can no longer be regarded simply as a social
disease. Although it has long been known that the major elements
which lead to obesity as a chronic medical condition are both hereditary
and environmental, it is
certain that environmental factors impact greatly on underlying
hereditary tendencies. This is certainly the case with Type 2 Diabetes
Mellitus, and the Insulin Resistance Syndrome. There is gathering
evidence that the same principles are at work in the progression
of obesity, and its complications, both in the setting of Insulin
Resistance Syndrome and obesity not associated with Insulin Resistance.
Major patho-physiologic mechanisms are being identified
that tie together the disordered clinical manifestations of obesity
and its complications. Examples of this include the role of Leptin
in both obese and protein calorie-malnutrition states, inflammatory
status in the obese individuals and the adipokine connections to
vascular disease states, and alterations in energy metabolism (thyroid
physiology) associated with altered cytokine physiology (Leptin).
The relevance and investigation of these alterations
are critical not only to devising new pharmacologic agents to address
this altered physiology associated with obesity, but to identify
and address more clearly the role lifestyle, diet and exercise to
avoid the progressive morbidity and mortality associated with obesity.
In the scheme outlined below, several adipokines (adipose
cell derived cytokines) are reviewed. The challenge is to identify
other relative and connecting peptides and factors and to include
them in a broad general mechanistic format.
Leptin
Leptin originates from the fat cell. It
acts on the brain (hypothalamic satiety center -leptin receptor),
and peripheral tissues. It is released from the fat cell in amounts
proportional to the fat mass stored in adipose tissue.
It is released based on acute changes in energy intake
(eating) and is high following a meal and low in the fasting state.
In other words, it stimulates appetite and decreases when a person
is fed.
Leptin regulates the secretion (release) of several
hormones. Included are the gonadotropins (LH & FSH) which regulate
fertility and sex steroid production, as well as thyroid releasing
hormone and growth hormone. For example, in cases of starvation,
as in low food availability, anorexia nervosa or thin body habitus
/ decreased fat mass (genetic low fat mass, ballet dancers and runners)
leptin levels are very low and output of the pituitary hormones
that stimulate ovaries and responsible for normal cycling are low.
This leads to loss of periods (amenorrhea) and low estrogen.
Leptin infused in low weight amenorrheic women restores normal menstrual
cycling without increasing body weight and may normalize testosterone
levels in men with low body weight/ starvation states.
TSH may demonstrate hyporesponsiveness to hypothalamic
(TRH) stimulus, and in severe protein calorie malnutrition or chronic
wasting states may manifest as low or normal TSH with low or normal
FT4 and low levels of T3, characteristic of Sick Euthyroid Syndrome.
Growth hormone secretion and growth factor stimulation may be reduced
in obese individuals resulting in reductions in cardio-pulmonary
function and oxygen consumption. Clinical manifestations include
low energy and stamina, poor sleep and mood, and depression.
Although leptin deficiency has been recognized in
children - a cause of extreme obesity in early years, deficiency
of Leptin and derangements in Leptin receptors are responsible for
only 2% of obesity in children. Abnormalities in "downstream"
or post-receptor defects in leptin activity are responsible for
10% of childhood obesity.
Adults generally manifest abnormal Leptin physiology
as Leptin resistance, commonly seen in obese adults. Type 2 diabetes
is associated with insulin resistance and usually accompanied by
Leptin resistance.
Back to top
Resistin
Cytokine released by adipose tissue with receptors in liver, muscle
and brain, apparently associated with insulin resistance. Levels
are low during fasting and increase after a meal, with higher levels
associated with a high fat meal. As laboratory animals are fed high
fat meals and fat stores increase, Resistin secretion increases.
mRNA expression for Resistin is higher in abdominal fat stores than
in thigh adipose tissue. Infusion of resistin increases insulin
resistance and blood glucose, while neutralization of Resistin decreases
sugars and lowers insulin resistance.
In addition, with respect to endothelial (vascular)
activity, Resistin plays a role which is reciprocal to the actions
of adipokine, Adiponectin. Expression of Resistin induces the expression
of adhesive molecules (VCAMs) residing in the
circulation that increases the adhesion of leukocytes to vascular
endothelium, and may be the key to small vessel inflammation and
atherosclerosis.
Back to top
TNF Alpha
Tissue Necrosis Factor (TNF) alpha is secreted by macrophages,
endothelial cells, and muscles with larger amounts in adipose tissue
with increasing fat stores. TNF alpha plays a role in the regulation
and maintenance of fat cell mass. TNF alpha affects many aspects
of adipocyte function, from adipocyte development to lipid metabolism.
TNF alpha acts with IL-6 in liver cells, increases
insulin resistance and increases inflammatory markers.
Uncontrolled diabetic females have a higher risk of
cardiovascular disease. Risk was 50% higher in those individuals
and correlated with both high HbA1c and high
TNF alpha compared with low levels of both. Women with high TNF
alpha and lower HbA1c were at higher risk than those with the high
HbA1c and lower TNF alpha.
Back to top
Adiponectin
Adiponectin circulates in trimers and oligomers and acts at the
liver and muscle level. Levels are inversely related to intra-abdominal
fat mass. Low levels are associated with inflammatory markers such
as IL-6, C-Reactive Protein and TNF alpha and Plasminogen Activating
Factor. Production of Adiponectin seems to cause a reciprocal lowering
of TNF alpha production, lowering of insulin resistance and atherosclerosis.
Thiazolidinediones increase Adiponectin by increasing gene expression.
Back to top
Others
Ciliary Neurotropic Factor (CNTF)- appears to modulate
Leptin pathways, leads to weight loss even when Leptin levels are
unchanged.
Plasminogen Activating Inhibitory Factor (PAI-1)-
inflammatory molecule increasing inflammatory reactivity in vascualer
bed. Gene is induced by TNF alpha.
Angiotensinogen-dual role in genesis of hypertension
and increasing fatty acid synthesis in adipocyte.
Back to top
References
Click
here for full list of references.
|